Therapeutic potential of nanoparticulate systems for macrophage targeting
- 14 July 2005
- journal article
- review article
- Published by Elsevier in Biomaterials
- Vol. 26 (35) , 7260-7275
- https://doi.org/10.1016/j.biomaterials.2005.05.044
Abstract
No abstract availableKeywords
This publication has 164 references indexed in Scilit:
- Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in miceBiochemical and Biophysical Research Communications, 2004
- Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer modelCancer Gene Therapy, 2004
- Amphotericin-induced stridor: a review of stridor, amphotericin preparations, and their immunoregulatory effectsAnnals of Allergy, Asthma & Immunology, 2003
- Quercetin: Critical Evaluation as an Antileishmanial Agent In Vivo in Hamsters Using Different Vesicular Delivery ModesJournal of Drug Targeting, 2002
- Antisense Oligodeoxynucleotides Targeting Internal Exon Sequences Efficiently Regulate TNF-α ExpressionAntisense and Nucleic Acid Drug Development, 1999
- Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenouslyNuclear Medicine and Biology, 1995
- An investigation on the role of plasma and serum opsonins on the evternalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife Sciences, 1995
- Increased bone marrow toxicity of doxorubicin bound to nanoparticlesEuropean Journal Of Cancer, 1994
- The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908Life Sciences, 1987
- A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activityBiochemical and Biophysical Research Communications, 1980